PET imaging in pediatric neuroradiology: Current and future applications

Pediatric Radiology

Volumn 40, Issue 1, 2010, Pages 82-96

  Kim, Sunhee ^a   Salamon, Noriko ^b   Jackson, Hollie A ^c   Blüml, Stefan ^c   Panigrahy, Ashok ^a,c  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Epilepsy; Lymphoma; Pediatric brain tumors; PET CT

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN RECEPTOR; NICOTINIC RECEPTOR; OPIATE RECEPTOR; SEROTONIN 1A RECEPTOR; TRYPTOPHAN DERIVATIVE;

BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; BRAIN LYMPHOMA; BRAIN TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CORTICAL DYSPLASIA; DIAGNOSTIC ACCURACY; DIODE LASER; EPILEPSY; GLUCOSE BRAIN LEVEL; HEAD AND NECK TUMOR; HUMAN; MOLECULAR IMAGING; NEUROLOGIC DISEASE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE FIBER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUBEROUS SCLEROSIS;

BRAIN DISEASES; CHILD; FORECASTING; HUMANS; NEURORADIOGRAPHY; PEDIATRICS; POSITRON-EMISSION TOMOGRAPHY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 72949095872     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-009-1457-5     Document Type: Conference Paper

References (113)

1. S Basu H Zaidi M Houseni, et al. 2007 Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states Semin Nucl Med 37 223 239 17418154
2. H Minn S Leskinen-Kallio P Lindholm, et al. 1993 [18F]fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin J Comput Assist Tomogr 17 115 123 1:STN:280:DyaK3s7itlGktw%3D%3D 8419418
3. A Kole O Nieweg J Pruim, et al. 1997 Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET J Nucl Med 38 692 696 1:STN:280:DyaK2szhsVSrtQ%3D%3D 9170429
4. L Geworski BO Knoop M de Wit, et al. 2002 Multicenter comparison of calibration and cross calibration of PET scanners J Nucl Med 43 635 639 11994527
5. M Westerterp J Pruim W Oyen, et al. 2007 Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters Eur J Nucl Med Mol Imaging 34 392 404 17033848
6. R Boellaard 2009 Standards for PET image acquisition and quantitative data analysis J Nucl Med 50 11S 20S 1:CAS:528:DC%2BD1MXmtFahsb8%3D 19380405
7. CJ Hoekstra OS Hoekstra SG Stroobants, et al. 2002 Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET J Nucl Med 43 1304 1309 1:CAS:528:DC%2BD38XotlKjs70%3D 12368367
8. CJ Hoekstra I Paglianiti OS Hoekstra, et al. 2000 Monitoring response to therapy in cancer using [F-18]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods Eur J Nucl Med 27 731 743 1:CAS:528:DC%2BD3cXjsVOgtrs%3D 10901462
9. JF Eary DA Mankoff 1998 Tumor metabolic rates in sarcoma using FDG PET J Nucl Med 39 250 254 1:STN:280:DyaK1c7jsFOqtQ%3D%3D 9476930
10. VJ Lowe DM DeLong JM Hoffman, et al. 1995 Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy J Nucl Med 36 883 887 1:STN:280:DyaK2M3ls12qsg%3D%3D 7738668
11. L Gorospe S Raman J Echeveste, et al. 2005 Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients Nucl Med Common 26 671 687
12. YE Erdi SA Nehmeh T Pan, et al. 2004 The CT motion quantitation of lung lesions and its impact on PET-measured SUVs J Nucl Med 45 1287 1292 15299050
13. HT Chugani ME Phelps JC Mazziotta 1987 Positron emission tomography study of human brain functional development Ann Neurol 22 487 497 1:STN:280:DyaL1c7jt1Gqsw%3D%3D 3501693
14. C Kennedy L Sokoloff 1957 An adaptation of the nitrous oxide method to the study of the cerebral circulation in children; normal values for cerebral blood flow and cerebral metabolic rate in childhood J Clin Invest 36 1130 1137 1:CAS:528:DyaG2sXos1Cjug%3D%3D 13449166
15. HT Chugani 1992 Functional brain imaging in pediatrics Pediatr Clin North Am 39 777 799 1:STN:280:DyaK38zkt1Cltw%3D%3D 1635806
16. A Loessner A Alavi KU Lewandrowski, et al. 1995 Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age J Nucl Med 36 1141 1149 1:STN:280:DyaK2MzhtFShsQ%3D%3D 7790936
17. JB Chawluk A Alavi R Dann, et al. 1987 Positron emission tomography in aging and dementia: effect of cerebral atrophy J Nucl Med 28 431 437 1:STN:280:DyaL2s7pslKisA%3D%3D 3494824
18. SA Miura MB Shapiro CL Grady 1990 Effects of gender on glucose utilization rates in healthy humans: a positron emission tomography study J Neurosci Res 27 500 504 1:CAS:528:DyaK3MXnvFejtw%3D%3D 2079712
19. MJ Koepp FG Woermann 2005 Imaging structure and function in refractory focal epilepsy Lancet Neurol 4 42 53 15620856
20. J Engel WJ Brown DE Kuhl, et al. 1982 Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy Ann Neurol 12 518 528 6984318
21. TR Henry JC Mazziotta J Engel 1993 Interictal metabolic anatomy of mesial temporal lobe epilepsy Arch Neurol 50 582 589 1:STN:280:DyaK3s3nsleqsQ%3D%3D 8503794
22. TR Henry TL Babb J Engel, et al. 1994 Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy Ann Neurol 36 925 927 1:STN:280:DyaK2M%2FptFCltA%3D%3D 7998782
23. JD Duncan SD Moss DJ Bandy, et al. 1997 Use of positron emission tomography for presurgical localization of eloquent brain areas in children with seizures Pediatr Neurosurg 26 144 156 1:STN:280:DyaK1c%2FnvVynsg%3D%3D 9419031
24. WH Theodore 1992 MRI, PET, SPECT: interrelations, technical limits, and unanswered questions Epilepsy Res Suppl 5 127 134 1:STN:280: DyaK3s%2FjvFCgsw%3D%3D 1418441
25. ON Markand SS Spencer AR Anderson 1995 SPECT in epilepsy J Neuroimaging 5 suppl 1 S23 S33 7626834
26. S Spencer 1994 The relative contributions of MRI, SPECT, and PET imaging in epilepsy Epilepsia 35 Suppl. 6 S72 S89 8206016
27. F Semah MC Picot C Adam, et al. 1998 Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 51 1256 1262 1:STN:280:DyaK1M%2FjsVWmsw%3D%3D 9818842
28. DS Lee SK Lee J-K Chung, et al. 1997 Predictive values of F-18-FDG PET and ictal SPECT to find epileptogenic zones in cryptogenic neocortical epilepsies (abstract) J Nucl Med 38 272
29. HT Chugani WD Shields DA Shewmon, et al. 1990 Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment Ann Neurol 27 406 413 1:STN:280:DyaK3c3ot1CgtA%3D%3D 2353794
30. BE Swartz C Brown MA Mandelkern, et al. 2002 The use of 2-deoxy-2[18F] fluoro-D-glucose (FDG-PET) positron emission tomography in the routine diagnosis of epilepsy Mol Imaging Biol 4 245 252 14537129
31. RM Debets B Sadzot JW van Isselt, et al. 1997 Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry 62 141 150 1:STN:280:DyaK2s3gtVyrtw%3D%3D 9048714
32. SS Ho SF Berkovic SU Berlangieri, et al. 1995 Comparison of ictal SPECT and interictal PET in the presurgical evaluation of temporal lobe epilepsy Ann Neurol 37 738 745 1:STN:280:DyaK2M3pslOltQ%3D%3D 7778847
33. TJ O'Brien RJ Hicks R Ware, et al. 2001 The utility of a 3-D, large-field-of-view, PENN-PET scanner in the presurgical evaluation of partial epilepsy J Nucl Med 42 1158 1165 11483674
34. O Muzik DC Chugani C Shen, et al. 1998 Objective method for localization of cortical asymmetries using positron emission tomography to aid surgical resection of epileptic foci Comput Aided Surg 3 74 82 1:STN:280: DyaK1M%2FgtFWgtg%3D%3D 9784955
35. TW Lin MA de Aburto M Dahlbom, et al. 2007 Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe J Nucl Med 48 776 782 17475967
36. HT Chugani DA Shewmon WD Shields, et al. 1993 Surgery for intractable infantile spasms: neuroimaging perspectives Epilepsia 34 764 771 1:STN:280:DyaK3szitFKkuw%3D%3D 8330590
37. Neuroimaging Subcommission of the International League Against Epilepsy 2000 Commission on diagnostic strategies: recommendations for functional neuroimaging of persons with epilepsy Epilepsia 41 1350 1356
38. N Salamon J Kung SJ Shaw, et al. 2008 FDG-PET-MRI coregistration improves detection of cortical dysplasia in patients with epilepsy Neurology 71 1594 1601 1:STN:280:DC%2BD1cjjt1Gmsg%3D%3D 19001249
39. AA Cohen-Gadol BG Wilhelmi F Collignon, et al. 2006 Long-term outcome of epilepsy surgery among 399 patients with nonlesional seizure foci including mesial temporal lobe sclerosis J Neurosurg 104 513 524 16619654
40. A Palmini HO Lüders 2002 Classification issues in malformations caused by abnormalities of cortical development Neurosurg Clin N Am 13 1 16 11754312 vii
41. A Palmini I Najm G Avanzini, et al. 2004 Terminology and classification of the cortical dysplasias Neurology 62 6 Suppl 3 S2 S8 1:STN:280: DC%2BD2c7ksVektQ%3D%3D 15037671
42. P Krsek B Maton B Korman, et al. 2008 Different features of histopathological subtypes of pediatric focal cortical dysplasia Ann Neurol 63 758 769 18571798
43. P Widdess-Walsh C Kellinghaus L Jeha, et al. 2005 Electro-clinical and imaging characteristics of focal cortical dysplasia: correlation with pathological subtypes Epilepsy Res 67 25 33 16181772
44. JA Lawson S Birchansky E Pacheco, et al. 2005 Distinct clinicopathologic subtypes of cortical dysplasia of Taylor Neurology 64 55 61 1:STN:280: DC%2BD2M%2FhslCmuw%3D%3D 15642904
45. DM Olson HT Chugani DA Shewmon, et al. 1990 Electrocorticographic confirmation of focal positron emission tomographic abnormalities in children with intractable epilepsy Epilepsia 31 731 739 1:STN:280:DyaK3M%2FlvFymsg%3D%3D 2245803
46. P Curatolo R Bombardieri M Verdecchia, et al. 2005 Intractable seizures in tuberous sclerosis complex: from molecular pathogenesis to the rationale for treatment J Child Neurol 20 318 325 15921233
47. BN Kalantari N Salamon 2008 Neuroimaging of tuberous sclerosis: spectrum of pathologic findings and frontiers in imaging AJR 190 W304 W309 18430816
48. S Koh P Jayakar C Dunoyer, et al. 2000 Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome Epilepsia 41 1206 1213 1:STN:280:DC%2BD3cvks12ruw%3D%3D 10999561
49. R Cusmai C Chiron P Curatolo, et al. 1990 Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis Epilepsia 31 747 755 1:STN:280:DyaK3M%2FlvFymsA%3D%3D 2245805
50. PS Chandra N Salamon J Huang, et al. 2006 FDG-PET/MRI coregistration and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in patients with tuberous sclerosis complex: a preliminary report Epilepsia 47 1543 1549 16981871
51. D Lardinois W Weder T Hany, et al. 2003 Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography N Engl J Med 348 2500 2507 12815135 (Pubitemid 36706537)
52. TF Hany HC Steinhert GW Goerres, et al. 2002 PET diagnostic accuracy: improvement with in line PET-CT system: initial results Radiology 225 575 581 12409597
53. G Antoch LS Freudenberg J Stattaus, et al. 2002 Whole body positron emission tomography-CT: optimized CT using oral and IV contrast materials AJR 179 1555 1560 12438054
54. MB McCarville R Christie N Daw, et al. 2005 PET/CT in the evaluation of childhood sarcomas AJR 184 1293 1304 15788613
55. SC Kaste 2004 Issues specific to implementation of PET-CT for pediatric oncology: what we have learned along the way Pediatr Radiol 34 205 213 14745525
56. BL Shulkin 2004 PET imaging in pediatric oncology Pediatr Radiol 34 199 204 14745526
57. MM Hudson MJ Krasin SC Kaste 2004 PET imaging in pediatric Hodgkin's lymphoma Pediatr Radiol 34 190 198 14745528
58. SC Kaste SC Howard EB McCarville, et al. 2005 18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's Pediatr Radiol 35 141 154 15654605
59. AF Shields JR Grierson BM Dohmen, et al. 1998 Imaging proliferation in vivo with [F-18]FLT and positron emission tomography Nat Med 4 1334 1336 1:CAS:528:DyaK1cXntlaqsrk%3D 9809561
60. RL Van Heertum EA Greenstein RS Tikofsky 2004 2-deoxy-fluorglucose-PET imaging of the brain: current clinical applications with emphasis on dementia Semin Nucl Med 34 300 312 15493007
61. G Di Chiro RL DeLaPaz RA Brooks, et al. 1982 Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography Neurology 32 1323 1329 6983044
62. M Sasaki Y Kuwabara T Toshida, et al. 1998 A comparative study of thallium-201 SPECT, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumors Eur J Nucl Med 25 1261 1269 1:STN:280:DyaK1czptFOitA%3D%3D 9724375
63. T Ogawa A Inugami J Hatazawa, et al. 1996 Clinical positron tomography for brain tumors: comparison of fludeoxyglucose F18and L-methy-C-11-methionine AJNR 17 345 353 1:STN:280:DyaK2s%2Fpt1Gqsw%3D%3D 8938309
64. JK Chung YK Kim SK Kim, et al. 2002 Usefulness of C-11-methionine PET in the evaluation of brain lesions that are hypo or isometabolic on F-18-FDG PET Eur J Nucl Med Mol Imaging 29 176 182 1:CAS:528:DC%2BD38XnvFSmtg%3D%3D 11926379
65. PL Jager W Vaalburg J Pruim, et al. 2001 Radiolabelled amino acids: basic aspects and clinical application in oncology J Nucl Med 42 432 445 1:CAS:528:DC%2BD3MXmvFOqt7k%3D 11337520
66. AM Spence M Muzi DA Mankoff, et al. 2004 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter J Nucl Med 45 1653 1659 15471829
67. EE Kim SK Chung TP Hayne, et al. 1992 Differentiation of residual or recurrent tumors from post-treatment change with F-18 FDG PET Radiographics 12 269 279 1:STN:280:DyaK383itFSmsQ%3D%3D 1561416
68. K Herholz LW Kracht WD Heiss 2003 Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET J Neuroimaging 13 269 271 1:STN:280:DC%2BD3szlslWksQ%3D%3D 12889176
69. N Galldiks LW Kracht L Burghaus, et al. 2006 Use of 11C methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas Eur J Nucl Med Mol Imaging 33 516 524 1:CAS:528:DC%2BD28XktFSqsLY%3D 16450140
70. B Pirotte S Goldman N Massager, et al. 2004 Comparison of F-18-FDG and C-11-methionine for PET-guided stereotactic brain biopsy of glioma J Nucl Med 45 1293 1298 1:CAS:528:DC%2BD2cXnsFSmur0%3D 15299051
71. 18F-FDG PET and evaluation of diagnostic accuracy J Nucl Med 47 6904 6911
72. G Williams FH Fahey ST Treves, et al. 2008 Exploratory evaluation of two-dimensional and three-dimensional methods of FDG PET quantification in pediatric anaplastic astrocytoma: a report from the Pediatric Brain Tumor Consortium (PBTC) Eur J Nucl Med Mol Imaging 35 1651 1658 18425516
73. JO Barentsz GJ Jager JA Witjes, et al. 1996 Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT Eur Radiol 6 129 133 1:STN:280:DyaK28zptV2qtw%3D%3D 8797968
74. DL Kent DR Haynor WT Longstreth Jr, et al. 1994 The clinical efficacy of magnetic resonance imaging in neuroimaging Ann Intern Med 120 856 871 1:STN:280:DyaK2c3gsFOksg%3D%3D 7818632
75. R Prabhakar KP Haresh T Ganesh, et al. 2007 Comparison of computed tomography and magnetic resonance based target volume in brain tumors J Cancer Res Ther 3 121 123 1:STN:280:DC%2BD2snntlGhug%3D%3D 17998738
76. B Pichler H Wehrl A Kolb, et al. 2008 Positron emission tomography/magnetic resonance imaging: the next generation of multimodality imaging? Semin Nucl Med 38 199 208 18396179
77. ME Casey R Nutt 1986 A multicrystal two-dimensional BGO detector system for positron emission tomography IEEE Trans Nucl Sci 33 460 463
78. S Yamamoto K Kuroda M Senda 2003 Scintillator selection for MR-compatible gamma detectors IEEE Trans Nucl Sci 50 1683 1685 1:CAS:528:DC%2BD2cXjsFSrsrc%3D
79. RB Slates K Farahani Y Shao, et al. 1999 A study of artefacts in simultaneous PET and MR imaging using a prototype MR-compatible pet scanner Phys Med Biol 44 2015 2027 1:STN:280:DyaK1MvgtVWqsg%3D%3D 10473211
80. C Catana Y Wu MS Judenhofer, et al. 2006 Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner J Nucl Med 47 1968 1976 17138739
81. BJ Pichler BK Swann J Rochelle, et al. 2004 Lutetium oxyorthosilicate block detector readout by avalanche photodiode arrays for high resolution animal PET Phys Med Biol 49 4305 4319 1:CAS:528:DC%2BD2cXptFWjsr0%3D 15509067
82. AJ Lucas RC Hawkes RE Ansorge, et al. 2006 Development of a combined microPET-MR system Technol Cancer Res Treat 5 337 341 1:STN:280: DC%2BD28vksFGltw%3D%3D 16866564
83. Lucas A, Hawkes RC, Guerra P et al (2006) Development of a combined micro-PET-MR system. IEEE Nucl Sci Symp Conf Rec 2345-2348
84. KM Gilbert WB Handler TJ Scholl, et al. 2006 Design of field-cycled magnetic resonance systems for small animal imaging Phys Med Biol 51 2825 2841 1:STN:280:DC%2BD283psVWrtA%3D%3D 16723769
85. WB Handler KM Gilbert H Peng, et al. 2006 Simulation of scattering and attenuation of 511 keV photons in a combined PET/field-cycled MRI system Phys Med Biol 51 2479 2491 16675864
86. M Schmand Z Burbar JL Corbeil, et al. 2007 Brain PET: first human tomography for simultaneous (functional) PET and MR imaging J Nucl Med Suppl 48 Suppl 2 45P Abstract 151
87. H-P Schlemmer BJ Pichler K Wienhard, et al. 2007 Simultaneous MR/PET for brain imaging: first patient scans J Nucl Med Suppl 48 Suppl 2 45P Abstract 152
88. C Muller-Horvat P Radny TK Eigentler, et al. 2006 Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma Eur J Cancer 42 342 350 16364631
89. W Heiss K Herholz 2006 Brain receptor imaging J Nucl Med 47 302 312 1:CAS:528:DC%2BD28Xhslantrk%3D 16455637
90. DM Treiman 2001 GABAergic mechanisms in epilepsy Epilepsia 42 8 12 11520315
91. A Hammers MJ Koepp DJ Brooks, et al. 2005 Periventricular white matter flumazenil binding and postoperative outcome in hippocampal sclerosis Epilepsia 46 944 948 15946336
92. A Hammers MJ Koepp MP Richardson, et al. 2003 Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI. A PET study of 44 patients Brain 126 1300 1318 12764053
93. FC Tortella JB Long 1985 Endogenous anticonvulsant substance in rat cerebrospinal fluid after a generalized seizure Science 228 1106 1108 1:CAS:528:DyaL2MXktVCmtLk%3D 2986292
94. JJ Frost HS Mayberg RS Fisher, et al. 1988 Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy Ann Neurol 23 231 237 1:STN:280:DyaL1c3jvFCqsA%3D%3D 2837132
95. HS Mayberg B Sadzot CC Meltzer, et al. 1991 Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography Ann Neurol 30 3 11 1:STN:280:DyaK38%2FislGhtg%3D%3D 1656846
96. I Madar RP Lesser G Krauss, et al. 1997 Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography Ann Neurol 41 358 367 1:CAS:528:DyaK2sXit1amuro%3D 9066357
97. A Hammers MC Asselin R Hinz, et al. 2007 Upregulation of opioid receptor binding following spontaneous epileptic seizures Brain 130 1009 1016 17301080
98. MT Toczek RE Carson L Lang, et al. 2003 PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy Neurology 60 749 756 1:CAS:528:DC%2BD3sXht1Kjt7c%3D 12629228
99. GC Teskey KS Radford I Seif, et al. 2004 MAOA knockout mice are more susceptible to seizures but show reduced epileptogenesis Epilepsy Res 59 25 34 1:CAS:528:DC%2BD2cXjvVGmsbk%3D 15135164
100. D Louw GB Sutherland GB Glavin, et al. 1989 A study of monoamine metabolism in human epilepsy Can J Neurol Sci 16 394 397 1:STN:280: DyaK3c%2FivF2htg%3D%3D 2478277
101. M Pintor IN Mefford I Hutter, et al. 1990 The levels of biogenic amines, their metabolites and tyrosine hydroxylase in the human epileptic temporal cortex Synapse 5 152 156 1:CAS:528:DyaK3cXltFeiu7g%3D 1968684
102. S Trottier B Evrard JP Vignal, et al. 1996 The serotonergic innervation of the cerebral cortex in man and its changes in focal cortical dysplasia Epilepsy Res 25 79 106 1:STN:280:DyaK2s%2FjvVGrtA%3D%3D 8884167
103. WH Theodore G Hasler G Giovacchini, et al. 2007 Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy Epilepsia 48 1526 1530 17442003 (Pubitemid 47245794)
104. M Diksic S Nagahiro T Chaly, et al. 1991 Serotonin synthesis rate measured in living dog brain by positron emission tomography J Neurochem 56 153 162 1:CAS:528:DyaK3MXlsFymtg%3D%3D 1987317
105. DC Chugani O Muzik P Chakraborty, et al. 1998 Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan Synapse 28 33 43 1:CAS:528:DyaK2sXns1Kmtrs%3D 9414016
106. O Muzik DC Chugani P Chakraborty, et al. 1997 Analysis of [C-11] alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo J Cereb Blood Flow Metab 17 659 669 1:CAS:528:DyaK2sXlsVGiurk%3D 9236722
107. DC Chugani HT Chugani O Muzik, et al. 1998 Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl- L-tryptophan positron emission tomography Ann Neurol 44 858 866 1:STN:280:DyaK1M%2Fms1Omtg%3D%3D 9851429
108. M Fedi DC Reutens F Andermann, et al. 2003 alpha-[11C]-methyl-L- tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency Epilepsy Res 52 203 213 12536053
109. M Fedi D Reutens H Okazawa, et al. 2001 Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin Neurology 57 1629 1636 1:CAS:528:DC%2BD38XnslY%3D 11706103
110. C Juhasz DC Chugani O Muzik, et al. 2003 Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy Neurology 60 960 968 1:STN:280:DC%2BD3s7ktVKqsA%3D%3D 12654960
111. GD Rosen D Burstein AM Galaburda 2000 Changes in efferent and afferent connectivity in rats with induced cerebrocortical microgyria J Comp Neurol 418 423 440 1:STN:280:DC%2BD3c7nvF2rtQ%3D%3D 10713571
112. DC Chugani 2004 Serotonin in autism and pediatric epilepsies Ment Retard Dev Disabil Res Rev 10 112 116 15362166
113. F Picard D Bruel D Servent, et al. 2006 Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study Brain 129 2047 2060 1:STN:280:DC%2BD28vks1KqtQ%3D%3D 16815873